Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Romidepsin, sold under the brand name Istodax, is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs). Romidepsin is a natural product obtained from the bacterium Chromobacterium violaceum, and works by blocking enzymes known as histone deacetylases, thus inducing apoptosis. It is sometimes referred…
History & Products
Explore the main themes, entities and connections around Romidepsin. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
histone ctcl peripheral administration t-cell lymphoma trials model cell effect inhibitor phase treatment trial patients involving also increased hdac cutaneous
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Romidepsin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Romidepsin | ATC code | L01XH02 (WHO) | 1.00 | infobox |
| Romidepsin | Bioavailability | Not applicable (IV only) | 1.00 | infobox |
| Romidepsin | CAS Number | 128517-07-7 N | 1.00 | infobox |
| Romidepsin | ChEBI | CHEBI:61080 N | 1.00 | infobox |
| Romidepsin | ChEMBL | ChEMBL1213490 N | 1.00 | infobox |
| Romidepsin | ChemSpider | 10122002 | 1.00 | infobox |
| Romidepsin | CompTox Dashboard (EPA) | DTXSID8048579 | 1.00 | infobox |
| Romidepsin | DrugBank | DB06176 Y | 1.00 | infobox |
| Romidepsin | ECHA InfoCard | 100.211.884 | 1.00 | infobox |
| Romidepsin | Elimination half-life | 3 hours | 1.00 | infobox |
| Romidepsin | Formula | C24H36N4O6S2 | 1.00 | infobox |
| Romidepsin | IUPHAR/BPS | 7006 | 1.00 | infobox |
| Romidepsin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Romidepsin | Legal status | US: ℞-only | 1.00 | infobox |
| Romidepsin | License data | US FDA: Romidepsin | 1.00 | infobox |
| Romidepsin | MedlinePlus | a610005 | 1.00 | infobox |
| Romidepsin | Metabolism | Liver (mostly CYP3A4-mediated) | 1.00 | infobox |
| Romidepsin | Molar mass | 540.69 g·mol−1 | 1.00 | infobox |
| Romidepsin | Other names | FK228; FR901228; Istodax | 1.00 | infobox |
| Romidepsin | Protein binding | 92–94% | 1.00 | infobox |
| Romidepsin | PubChem CID | 5352062 | 1.00 | infobox |
| Romidepsin | Routes of administration | Intravenous infusion | 1.00 | infobox |
| Romidepsin | Trade names | Istodax | 1.00 | infobox |
| Romidepsin | UNII | CX3T89XQBK | 1.00 | infobox |
| Romidepsin | is a | natural product obtained from the bacterium Chromobacterium violaceum | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.